MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, QLGN has $43,470,364 in assets. $38,777,166 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
882.91%
Cash Ratio
787.63%
Assets Breakdown
    • Cash and cash equivalents
    • Short-term notes receivable, net...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock, 0.001 par value...
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
2025-06-30
2025-03-31
Cash and cash equivalents
38,777,166 331,601 30,210
Prepaid expenses and other current assets
343,091 316,576 565,765
Other current assets
--20,000
Short-term notes receivable, net of allowance for credit losses of 261,000 at september 30, 2025 and 360,000 at december 31, 2024
4,348,107 3,312,496 2,229,563
Total current assets
43,468,364 3,960,673 2,845,538
Other assets
2,000 2,000 2,000
Total assets
43,470,364 3,962,673 2,847,538
Accounts payable
1,282,224 1,404,611 1,530,735
Accrued expenses and other current liabilities
41,896 379,633 210,104
Warrant liabilities
362,323 213,976 229,950
Convertible debt
339,736 142,069 -
Promissory notes
2,897,107 3,474,667 843,615
Total current liabilities
4,923,286 5,614,956 2,814,404
Preferred stock, 0.001 par value 15,000,000 shares authorized 45,044 and 6,256 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
36,100,334 2,790,007 2,823,094
Common stock, 0.001 par value 225,000,000 shares authorized 3,056,822 and 736,431 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
67,734 66,213 66,203
Additional paid-in capital
131,809,991 122,884,659 122,851,582
Accumulated deficit
-129,430,981 -127,393,162 -125,707,745
Total stockholders equity
--33,134
Total stockholders equity (deficit)
38,547,078 -1,652,283 -
Total liabilities & stockholders equity (deficit)
43,470,364 3,962,673 2,847,538
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term notesreceivable, net of allowance...$4,348,107 Prepaid expenses andother current assets$343,091 Cash and cashequivalents$38,777,166 Other assets$2,000 Total current assets$43,468,364 Total assets$43,470,364 Total liabilities &stockholders equity...$43,470,364 Total stockholdersequity (deficit)$38,547,078 Total currentliabilities$4,923,286 Accumulated deficit-$129,430,981 Additional paid-in capital$131,809,991 Promissory notes$2,897,107 Convertible debt$339,736 Warrant liabilities$362,323 Accrued expenses andother current...$41,896 Accounts payable$1,282,224 Common stock, 0.001 parvalue 225,000,000...$67,734 Preferred stock, 0.001 parvalue 15,000,000...$36,100,334

Qualigen Therapeutics, Inc. (QLGN)

Qualigen Therapeutics, Inc. (QLGN)